Tuesday, November 25, 2025

Tuesday, November 25, 2025

FDA Approval

Latest News

No Results

Trending

  1. 1 GT BIOPHARMA: Announces FDA Data - GTB-3550 Trike™ Reduces Cancer Cells by 61.7% for a High-risk Myelodysplastic Syndromes (HR-MDS) Patient
  2. 2 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
FDA Health News